Three new #GLP 1 drugs for obesity treatment2 injectables and 1 pillmay receive FDA approval this year. Here's how high dose semaglutide, cagrilintide plus semaglutide, and orforglipron performed in phase 3 trials. Structure Therapeutics: Key Milestones Dead Ahead (NASDAQ:GPCR) Seeking Alpha Semaglutide: price and HTA comparison US and European markets Cagrilintide vs Retatrutide for Weight Loss and Metabolic Health BetteryouRx Cagrilintide Combined with Semaglutide: A New Approach for Treatment of Obesity and Type 2 Diabetes ClinicSearch New experimental drug cagrilintide (AM833), when combined with emaglutide, shows potential for treatment of obesity